Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 25th Congress of the European Association of Urology
Androgen Deprivation Therapy in Prostate Cancer
Barcelona, Spain / April 16-20, 2010
Barcelona - New data have reinforced the utility of a gonadotropin-releasing hormone (GnRH) receptor blocker for slowing progression of advanced prostate cancer. Following a previous phase III study in which this agent compared favourably...
PRIORITY PRESS - 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Fluoroquinolones in the Management of Community-acquired Pneumonia
Vienna, Austria / April 10-13, 2010
Vienna - Community-acquired pneumonia (CAP) predominantly affects elderly people and causes substantial morbidity and mortality. The long hospital stays required generate high health-care costs. The most important pathogen in CAP is...
PRIORITY PRESS - 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
Broadening Vaccine Serotype Coverage Against Emerging Antibiotic Resistance
Vienna, Austria / April 10-13, 2010
Vienna - The burden of pneumococcal diseases caused by Streptococcus pneumoniae is particularly high among young children and those aged over 65 years. In 2000, the 7-valent conjugate pneumococcal vaccine (PCV7) was approved for use in...
PRIORITY PRESS - 20th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
New Developments in the Treatment of MRSA and Other Infectious Diseases
Vienna, Austria / April 10-13, 2010
Vienna - Advances in the use of respiratory fluoroquinolones—which are extremely active against Streptococcus pneumoniae—have represented a major development in treating community-acquired pneumonia. However, indiscriminate use of these and...
MEDI-NEWS - Based on Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31:431-55.
Guidelines for Clostridium difficile in Adults
April 2010
The Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) recently released updated guidelines for the management of Clostridium difficile. Since their last position paper published in...
PRIORITY PRESS - 36th Annual Meeting of the European Group for Blood and Bone Marrow Transplantation (EBMT)
New Antifungal Strategies in High-risk Stem Cell Transplant Recipients
Vienna, Austria / March 21-24, 2010
Vienna - Although Candida infection is still probably the most widespread fungal infection in a surgical setting, Aspergillus and other mold pathogens are a substantial cause of morbidity and mortality in immunosuppressed patients. In...
PRIORITY PRESS - 36th Annual Meeting of the European Group for Blood and Bone Marrow Transplantation (EBMT)
Progress in Infection Management of Allogeneic Stem Cell Recipients
Vienna, Austria / March 21-24, 2010
Vienna - In the last 10 years, widespread use of allogeneic hematopoietic stem cell transplantation has decreased the risk of recurrence in patients with aggressive hematological malignancies. However, the associated conditioning and...
PRIORITY PRESS - 59th Annual Scientific Session of the American College of Cardiology
New Treatment Strategies for CABG Patients with Acute Coronary Syndrome
Atlanta, Georgia / March 14-16, 2010
Atlanta - In patients with acute coronary syndromes (ACS), new data re-emphasize that an emerging generation of more potent antiplatelet agents are reducing major vascular events relative to clopidogrel. In a new analysis presented here at...
PRIORITY PRESS - 59th Annual Scientific Session of the American College of Cardiology
Advances in Dyslipidemia Management: Extending the Clinical Benefit
Atlanta, Georgia / March 14-16, 2010
Atlanta - A statin has been licensed for reduction of cardiovascular (CV) risk in patients without a traditionally defined elevation in LDL-C. The newly released indication was similarly defined by both Health Canada and the U.S. Food and...